John Vavricka
Chief Commercial Officer · 1 filing · Latest: Jan 31, 2026
Atea Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AVIR | John Vavricka | Chief Commercial Officer | Jan 31, 2026 | Option Exercise | — | 42,083 | — | 94,164 |